Notice of Intent: Direct Human Total Lymphocyte Isolation Kits

The Defense Health Agency (DHA) intends to award a firm fixed price contract on a sole source basis to StemCell Technology for the procurement of Direct Human Total Lymphocyte Isolation Kits. These kits are designed to work exclusively with EasySep magnets. The contract is being awarded under the statutory authority permitting Other than Full and Open Competition. Interested parties may identify their interest and capabilities by responding to this notice by email. • The contract is for a specific type of kit designed to work with EasySep magnets. • The award will be made on a sole source basis to StemCell Technology. • The notice is not a request for competitive proposals or quotations. • Interested parties may respond to the notice by email to identify their interest and capabilities.